(Q44854785)

6 December 2017

Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease (English)

1 reference

Human T-lymphotropic virus 1

6 December 2017

1 reference

1 reference

1 reference

1 reference

7

1 reference

6 December 2017

2

Irene T Weber

1 reference

6 December 2017

János Kádas

1

1 reference

6 December 2017

Péter Bagossi

3

1 reference

6 December 2017

Gabriella Miklóssy

4

1 reference

6 December 2017

Péter Boross

5

1 reference

6 December 2017

Stephen Oroszlan

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

20 April 2004

1 reference

Journal of Biological Chemistry

6 December 2017

1 reference

6 December 2017

279

1 reference

6 December 2017

26

1 reference

6 December 2017

27148-27157

1 reference

Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance

6 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Novel compounds in preclinical/early clinical development for the treatment of HIV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Oncogenic retroviruses in animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Understanding HTLV-I protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Substrates and inhibitors of human T-cell leukemia virus type I protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Subsite preferences of retroviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

17 The kinetics of reversible tight-binding inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structure of equine infectious anemia virus proteinase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

RASMOL: biomolecular graphics for all

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401868200

21 January 2018

Identifiers

DOI

10.1074/JBC.M401868200

1 reference

release_exp6sktcbvftjclrv36i5dbmpq

6 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/exp6sktcbvftjclrv36i5dbmpq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference